Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical Trial

Chuan Huan Chuah, Bai Han Ooi, Heng Gee Lee(Queen Elizabeth Hospital), Nurul Ashikin Adnan(Hospital Sultanah Nur Zahirah), Chee Peng Hor(Hospital Seberang Jaya), Ting Soo Chow(Penang Adventist Hospital), Yi Fang Lim, Shalini Vijayasingham(Hospital Sungai Buloh), Kok Soon Lee, Delarina Frimawati Othman Andu, Tiang Koi Ng(Hospital Tuanku Ja’afar), Joo Thye Cheng, Mahiran Mustafa(Hospital Raja Perempuan Zainab II), Chun Keat Chew, Chin Tho Leong, Mohan Dass Pathmanathan(Ministry of Health), Kalaiarasu M. Peariasamy(Ministry of Health), Suresh Kumar Chidambaram(Hospital Sungai Buloh), Noorlina Nordin(Hospital Tengku Ampuan Afzan), Su Miin Ong(National Institutes of Health), Suhaila Abdul Wahab, Nicholas Hee Ken Yoong(RCSI & UCD Malaysia Campus), Qin Le Tay, Divya Rajendra R Ajmera, Yik Zhi Kum, Peter Andrew Natarajan, Pei Sun Tan, Ammar Rashidi Abdullah, Karamjit Kaur Sarban Singh, Masliza Zaid(Sultanah Aminah Hospital), Seri Rabiatul Nur Abu Salim, Kar Nim Leong, Chung Yeow Wong(RCSI & UCD Malaysia Campus), Hong Bee Ker, Nurnadiah Kamarudin, Yee Jie Teoh, Nor Zaila Binti Zaidan(Malacca General Hospital), Jian Hao Sim, Tze Yuan Tee, Peng Shyan Wong, Muhammad Luqman Hamzah
Clinical Infectious Diseases
November 16, 2021
Cited by 47


Related Papers